# Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

> **NCT07266155** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Longbio Pharma** · enrollment: 30 (estimated)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

- **BIOLOGICAL:** LP-005 Injection

## Key facts

- **NCT ID:** NCT07266155
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07266155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07266155, "Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07266155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*